General Information of Drug Off-Target (DOT) (ID: OT0OUDUT)

DOT Name Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A)
Synonyms IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIa; FcRII-a; CD antigen CD32
Gene Name FCGR2A
UniProt ID
FCG2A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1FCG; 1H9V; 3D5O; 3RY4; 3RY5; 3RY6
Pfam ID
PF13895
Sequence
MTMETQMSQNVCPRNLWLLQPLTVLLLLASADSQAAAPPKAVLKLEPPWINVLQEDSVTL
TCQGARSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVL
SEWLVLQTPHLEFQEGETIMLRCHSWKDKPLVKVTFFQNGKSQKFSHLDPTFSIPQANHS
HSGDYHCTGNIGYTLFSSKPVTITVQVPSMGSSSPMGIIVAVVIATAVAAIVAAVVALIY
CRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQLEETNNDYETADGGYMTLNPRAPTDDD
KNIYLTLPPNDHVNSNN
Function
Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens.
Tissue Specificity Found on monocytes, neutrophils and eosinophil platelets.
KEGG Pathway
Phagosome (hsa04145 )
Osteoclast differentiation (hsa04380 )
Platelet activation (hsa04611 )
Neutrophil extracellular trap formation (hsa04613 )
Fc gamma R-mediated phagocytosis (hsa04666 )
Pathogenic Escherichia coli infection (hsa05130 )
Yersinia infection (hsa05135 )
Leishmaniasis (hsa05140 )
Staphylococcus aureus infection (hsa05150 )
Tuberculosis (hsa05152 )
Coro.virus disease - COVID-19 (hsa05171 )
Systemic lupus erythematosus (hsa05322 )
Reactome Pathway
Regulation of actin dynamics for phagocytic cup formation (R-HSA-2029482 )
Role of phospholipids in phagocytosis (R-HSA-2029485 )
Neutrophil degranulation (R-HSA-6798695 )
FCGR3A-mediated IL10 synthesis (R-HSA-9664323 )
FCGR activation (R-HSA-2029481 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Cetuximab DMLNCE0 Approved Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A) increases the response of Cetuximab. [8]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [1]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [2]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [3]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [4]
Methotrexate DM2TEOL Approved Methotrexate increases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [5]
Cytarabine DMZD5QR Approved Cytarabine increases the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [6]
Testosterone enanthate DMB6871 Approved Testosterone enanthate affects the expression of Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A). [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
2 Human 3D multicellular microtissues: an upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicol Lett. 2019 Sep 15;312:34-44.
3 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
4 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
5 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
6 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
7 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
8 FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. J Clin Oncol. 2007 Aug 20;25(24):3712-8. doi: 10.1200/JCO.2006.08.8021.